Advertising Disclaimer »

FDA UPDATE

Metabolic, endocrine drugs among 500 products with new pediatric information

Food and Drug Administration Office of Pediatric Therapeutics, Pediatric & Maternal Health Staff and Division of Metabolic and Endocrine Products
AAP News January 2014, 35 (1) 20; DOI: https://doi.org/10.1542/aapnews.2014351-20
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

AAP News: 35 (1)
AAP News
Vol. 35, Issue 1
1 Jan 2014
View this article with LENS
Email Article
Request Permissions
Article Alerts
Citation Tools
Metabolic, endocrine drugs among 500 products with new pediatric information
Food and Drug Administration Office of Pediatric Therapeutics, Pediatric & Maternal Health Staff, Division of Metabolic and Endocrine Products
AAP News Jan 2014, 35 (1) 20; DOI: 10.1542/aapnews.2014351-20
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF

Jump to section

Subjects